1378390-29-4 Usage
Description
3-(2-bromoacetyl)-10,11-dihydro-5H-Benzo[d]naphtho[2,3-b]pyran-8(9H)-one is a complex organic compound with a unique chemical structure. It is characterized by its antiviral properties and serves as an intermediate in the synthesis of Velpatasvir (V116000), a medication used to treat hepatitis C virus (HCV) infections.
Uses
Used in Pharmaceutical Industry:
3-(2-bromoacetyl)-10,11-dihydro-5H-Benzo[d]naphtho[2,3-b]pyran-8(9H)-one is used as an antiviral agent for the development of medications targeting hepatitis C virus (HCV) infections. Its role as an intermediate in the synthesis of Velpatasvir (V116000), a NS5A inhibitor, highlights its importance in the treatment of HCV.
Used in Antiviral Research:
3-(2-bromoacetyl)-10,11-dihydro-5H-Benzo[d]naphtho[2,3-b]pyran-8(9H)-one is also utilized in the field of antiviral research, where it contributes to the discovery and development of new antiviral drugs. Its unique chemical structure and antiviral properties make it a valuable asset in the ongoing fight against viral infections, particularly those caused by the hepatitis C virus.
Check Digit Verification of cas no
The CAS Registry Mumber 1378390-29-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,7,8,3,9 and 0 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1378390-29:
(9*1)+(8*3)+(7*7)+(6*8)+(5*3)+(4*9)+(3*0)+(2*2)+(1*9)=194
194 % 10 = 4
So 1378390-29-4 is a valid CAS Registry Number.
1378390-29-4Relevant articles and documents
PROCESSES FOR PREPARING ANTIVIRAL COMPOUNDS
-
, (2015/12/30)
The present disclosure provides processes for the preparation of a compound of formula: which is useful as an antiviral agent. The disclosure also provides compounds that are synthetic intermediates.
CONDENSED IMIDAZOLYLIMIDAZOLES AS ANTIVIRAL COMPOUNDS
-
, (2013/06/05)
The disclosure is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.